Alignment Healthcare (ALHC) Stock Analysis & Price (Updated Oct 16, 2026, 4:00 PM ET)
Updated Oct 16, 2026, 4:00 PM ET
- Closed at $8.28, +1.60% vs the prior close of $8.15.
- Volume 5.42M shares, 0.6x its 50-day average.
- No new SEC filings since the prior session.
- No new insider buys or sales reported since the prior session.
ALHC rises 1.6% to $8.28. Closed at $8.28, +1.60% vs the prior close of $8.15. Day range $8.02–$8.37, opened at $8.27.
ALHC daily analysis — what happened
A plain-English, data-only note written after every US trading day. Newest first; older days stay archived below.
Oct 16, 2026 — ALHC rises 1.6% to $8.28
- Closed at $8.28, +1.60% vs the prior close of $8.15. Day range $8.02–$8.37, opened at $8.27.
- Volume was 5.42M shares, 0.6x its 50-day average of 8.83M.
- Price is -24.3% vs its 50-day average ($10.94) and -52.5% vs its 200-day average ($17.45).
- 52-week range $6.01–$25.12; today's close sits at 12% of that range, 67.0% below the 52-week high.
Oct 15, 2026 — ALHC dips 1.0% to $8.15
- Closed at $8.15, -0.97% vs the prior close of $8.23. Day range $7.94–$8.44, opened at $8.27.
- Volume was 8.98M shares, 1.0x its 50-day average of 8.77M.
- Price is -26.2% vs its 50-day average ($11.04) and -53.4% vs its 200-day average ($17.50).
- 52-week range $6.01–$25.12; today's close sits at 11% of that range, 67.6% below the 52-week high.
Oct 14, 2026 — ALHC dips 0.8% to $8.23
- Closed at $8.23, -0.84% vs the prior close of $8.30. Day range $8.09–$8.53, opened at $8.39.
- Volume was 6.76M shares, 0.8x its 50-day average of 8.88M.
- Price is -26.2% vs its 50-day average ($11.15) and -53.1% vs its 200-day average ($17.55).
- 52-week range $6.01–$25.12; today's close sits at 12% of that range, 67.2% below the 52-week high.
Oct 13, 2026 — ALHC rises 2.6% to $8.30
- Closed at $8.30, +2.60% vs the prior close of $8.09. Day range $8.11–$8.49, opened at $8.26.
- Volume was 7.10M shares, 0.8x its 50-day average of 8.96M.
- Price is -26.3% vs its 50-day average ($11.26) and -52.9% vs its 200-day average ($17.61).
- 52-week range $6.01–$25.12; today's close sits at 12% of that range, 67.0% below the 52-week high.
Oct 12, 2026 — ALHC jumps 7.2% to $8.09
- Closed at $8.09, +7.22% vs the prior close of $7.55. Day range $7.48–$8.31, opened at $7.49.
- Volume was 9.89M shares, 1.1x its 50-day average of 9.11M.
- Price is -28.9% vs its 50-day average ($11.38) and -54.2% vs its 200-day average ($17.66).
- 52-week range $6.01–$25.12; today's close sits at 11% of that range, 67.8% below the 52-week high.
Oct 9, 2026 — ALHC slides 13.4% to $7.55, a 52-week low on 3.0x normal volume
- Closed at $7.55, -13.38% vs the prior close of $8.71. Day range $6.01–$7.71, opened at $6.93.
- Volume was 26.05M shares, 3.0x its 50-day average of 8.67M — unusually heavy trading.
- Price is -34.5% vs its 50-day average ($11.52) and -57.4% vs its 200-day average ($17.72).
- 52-week range $6.01–$25.12; today's close sits at 8% of that range, 70.0% below the 52-week high.
Oct 8, 2026 — ALHC rises 1.9% to $8.71
- Closed at $8.71, +1.87% vs the prior close of $8.55. Day range $8.37–$8.77, opened at $8.55.
- Volume was 11.01M shares, 1.3x its 50-day average of 8.52M.
- Price is -25.8% vs its 50-day average ($11.74) and -51.0% vs its 200-day average ($17.78).
- 52-week range $7.37–$25.12; today's close sits at 8% of that range, 65.3% below the 52-week high.
- SEC filings that day: 8-K.
Oct 7, 2026 — ALHC rises 2.2% to $8.55
- Closed at $8.55, +2.15% vs the prior close of $8.37. Day range $8.26–$8.78, opened at $8.30.
- Volume was 6.56M shares, 0.8x its 50-day average of 8.51M.
- Price is -28.3% vs its 50-day average ($11.93) and -52.1% vs its 200-day average ($17.84).
- 52-week range $7.37–$25.12; today's close sits at 7% of that range, 66.0% below the 52-week high.
Oct 6, 2026 — ALHC dips 1.5% to $8.37
- Closed at $8.37, -1.53% vs the prior close of $8.50. Day range $8.18–$8.73, opened at $8.44.
- Volume was 10.76M shares, 1.3x its 50-day average of 8.37M.
- Price is -31.0% vs its 50-day average ($12.13) and -53.2% vs its 200-day average ($17.90).
- 52-week range $7.37–$25.12; today's close sits at 6% of that range, 66.7% below the 52-week high.
Oct 5, 2026 — ALHC jumps 7.1% to $8.50
- Closed at $8.50, +7.05% vs the prior close of $7.94. Day range $8.00–$8.56, opened at $8.10.
- Volume was 10.28M shares, 1.2x its 50-day average of 8.23M.
- Price is -31.1% vs its 50-day average ($12.34) and -52.7% vs its 200-day average ($17.96).
- 52-week range $7.37–$25.12; today's close sits at 6% of that range, 66.2% below the 52-week high.
Oct 2, 2026 — ALHC rises 2.6% to $7.94
- Closed at $7.94, +2.58% vs the prior close of $7.74. Day range $7.70–$8.03, opened at $7.75.
- Volume was 9.80M shares, 1.2x its 50-day average of 8.10M.
- Price is -36.8% vs its 50-day average ($12.55) and -55.9% vs its 200-day average ($18.02).
- 52-week range $7.37–$25.12; today's close sits at 3% of that range, 68.4% below the 52-week high.
ALHC latest news & SEC filings
Every SEC filing by or about ALHC in the last 120 days, explained in plain English. Updated daily, with a same-day refresh for new filings.
Oct 8, 2026 · Form 8-K — Major event / current report
Current report — a filing companies must make within 4 business days of a major event
- Item 7.01 — Released information under Regulation FD (e.g. a presentation or press release).
Oct 7, 2026 · Form 4 — Insider trade
Insider trade report (Form 4) — a director, officer or 10%+ owner changed their holdings
- Kim Hyong sold 32,479 shares at $8.30 (≈$269.58K) on Oct 6, 2026; now holds 299,271
Open-market purchases (P) and sales (S) are shown in colour; awards, exercises and tax withholding are routine pay-related moves. Many sales are pre-planned under 10b5-1 plans.
Oct 5, 2026 · Form 144 — Planned insider sale
Notice of proposed sale (Form 144) — an insider or affiliate plans to sell restricted or control shares
A notice of intent, not a completed sale. Any actual sale by a director or officer shows up later on Form 4.
Oct 5, 2026 · Form SCHEDULE 13G/A — Update to a passive 5%+ stake (13G)
Update to a passive 5%+ stake (13G)
Filed by an outside investor (not the company). It reports a holding of more than 5% of a share class; percentage and holder name are in the filing.
Sep 18, 2026 · Form 4 — Insider trade
Insider trade report (Form 4) — a director, officer or 10%+ owner changed their holdings
- Konowiecki Joseph S sold 23,511 shares at $8.61 (≈$202.43K) on Sep 17, 2026; now holds 1,080,305
Open-market purchases (P) and sales (S) are shown in colour; awards, exercises and tax withholding are routine pay-related moves. Many sales are pre-planned under 10b5-1 plans.
Sep 16, 2026 · Form 4 — Insider trade
Insider trade report (Form 4) — a director, officer or 10%+ owner changed their holdings
- Kao John E sold 27,400 shares at $13.00 (≈$356.20K) on Sep 14, 2026; now holds 590,766
Open-market purchases (P) and sales (S) are shown in colour; awards, exercises and tax withholding are routine pay-related moves. Many sales are pre-planned under 10b5-1 plans.
Sep 16, 2026 · Form 144 — Planned insider sale
Notice of proposed sale (Form 144) — an insider or affiliate plans to sell restricted or control shares
A notice of intent, not a completed sale. Any actual sale by a director or officer shows up later on Form 4.
Sep 11, 2026 · Form 4 — Insider trade
Insider trade report (Form 4) — a director, officer or 10%+ owner changed their holdings
- Maroney Dawn Christine sold 122,707 shares at $12.68 (≈$1.56M) on Sep 11, 2026
- Maroney Dawn Christine sold 122,707 shares at $12.68 (≈$1.56M) on Sep 11, 2026
- Maroney Dawn Christine sold 122,707 shares at $12.68 (≈$1.56M) on Sep 11, 2026
- Maroney Dawn Christine sold 122,707 shares at $12.68 (≈$1.56M) on Sep 11, 2026
Open-market purchases (P) and sales (S) are shown in colour; awards, exercises and tax withholding are routine pay-related moves. Many sales are pre-planned under 10b5-1 plans.
Aug 13, 2026 · Form SCHEDULE 13G — Passive stake (13G)
Passive stake (13G) — an investor reported owning more than 5%
Filed by an outside investor (not the company). It reports a holding of more than 5% of a share class; percentage and holder name are in the filing.
Jul 31, 2026 · Form SCHEDULE 13G — Passive stake (13G)
Passive stake (13G) — an investor reported owning more than 5%
Filed by an outside investor (not the company). It reports a holding of more than 5% of a share class; percentage and holder name are in the filing.
Jul 30, 2026 · Form 10-Q — Quarterly report
Quarterly report (unaudited financial statements for the quarter)
Quarter ended Jun 30, 2026:
- Revenue: $1.34B (prior year $1.02B) (+31.6% vs Jun 30, 2025)
- Net income: $36.56M (prior year $15.67M) (+133.4% vs Jun 30, 2025)
- Diluted EPS: $0.17 (prior year $0.07) (+142.9% vs Jun 30, 2025)
Jul 30, 2026 · Form 8-K — Major event / current report
Current report — a filing companies must make within 4 business days of a major event
- Item 2.02 — Reported results of operations (earnings release).
This is a results-day filing: the earnings press release is attached as an exhibit.
Jul 27, 2026 · Form SCHEDULE 13G/A — Update to a passive 5%+ stake (13G)
Update to a passive 5%+ stake (13G)
Filed by an outside investor (not the company). It reports a holding of more than 5% of a share class; percentage and holder name are in the filing.
Things to know before you trade ALHC
- Last results release: Jul 30, 2026 (8-K Item 2.02). Previous ones: Apr 30, 2026, Feb 26, 2026, Oct 30, 2025. Based on that rhythm, the next report is likely around Oct 29, 2026 — an estimate, not a confirmed date.
- How much it moves: over the last 20 sessions the average daily move was 3.46% (largest 13.4%). That is a volatile stock.
- Liquidity: about 11.13M shares (≈$92.17M) trade per day on average.
- 52-week position: $8.28 vs a range of $6.01–$25.12 (12% of the range).
- Dividends: no cash dividends in the last 2 years.
- Splits: none in the last 2 years.
- Insider trades (Form 4, last 12 months, recent 25 shown): 0 open-market buys, 25 sales; latest: Joseph S Konowiecki sold 23,511 shares on Sep 17, 2026.
- Latest filings: 8-K Oct 8, 2026; 10-Q Jul 30, 2026; 8-K Jul 30, 2026.
- Share count: 207.44M shares outstanding (Jul 27, 2026), +4.7% vs a year earlier.
- Listing: Nasdaq · industry: Hospital & Medical Service Plans.
ALHC market data (last 20 sessions)
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Oct 16, 2026 | 8.27 | 8.37 | 8.02 | 8.28 | 5.42M |
| Oct 15, 2026 | 8.27 | 8.44 | 7.94 | 8.15 | 8.98M |
| Oct 14, 2026 | 8.39 | 8.53 | 8.09 | 8.23 | 6.76M |
| Oct 13, 2026 | 8.26 | 8.49 | 8.11 | 8.30 | 7.10M |
| Oct 12, 2026 | 7.49 | 8.31 | 7.48 | 8.09 | 9.89M |
| Oct 9, 2026 | 6.93 | 7.71 | 6.01 | 7.55 | 26.05M |
| Oct 8, 2026 | 8.55 | 8.77 | 8.37 | 8.71 | 11.01M |
| Oct 7, 2026 | 8.30 | 8.78 | 8.26 | 8.55 | 6.56M |
| Oct 6, 2026 | 8.44 | 8.73 | 8.18 | 8.37 | 10.76M |
| Oct 5, 2026 | 8.10 | 8.56 | 8.00 | 8.50 | 10.28M |
| Oct 2, 2026 | 7.75 | 8.03 | 7.70 | 7.94 | 9.80M |
| Oct 1, 2026 | 8.15 | 8.22 | 7.59 | 7.74 | 19.65M |
| Sep 30, 2026 | 7.92 | 8.18 | 7.77 | 8.16 | 8.79M |
| Sep 29, 2026 | 7.93 | 7.99 | 7.75 | 7.91 | 7.07M |
| Sep 28, 2026 | 8.12 | 8.27 | 7.84 | 7.93 | 8.66M |
| Sep 25, 2026 | 7.73 | 8.40 | 7.70 | 8.21 | 10.65M |
| Sep 24, 2026 | 7.92 | 7.97 | 7.37 | 7.67 | 15.93M |
| Sep 23, 2026 | 7.92 | 8.13 | 7.63 | 7.86 | 13.72M |
| Sep 22, 2026 | 8.44 | 8.50 | 7.85 | 7.99 | 11.96M |
| Sep 21, 2026 | 8.33 | 8.38 | 8.02 | 8.33 | 13.59M |
About Alignment Healthcare
Alignment Healthcare (ALHC) is listed on the Nasdaq and classified by the SEC under “Hospital & Medical Service Plans”. Its business address is in ORANGE, CA. State of incorporation: DE. Fiscal year ends December 31. SEC CIK 1832466.
ALHC board of directors & executives
From SEC Form 3/4/5 insider filings made in the last 12 months (date = latest filing).
Directors
| Name | Role | Latest filing |
|---|---|---|
| Jody L Bilney | Director | Mar 17, 2026 |
| David C Hodgson | Director | Mar 17, 2026 |
| Yon Jorden | Director | Mar 17, 2026 |
| John E Kao | Chief Executive Officer | Sep 16, 2026 |
| Joseph S Konowiecki | EVP, Corporate Affairs | Sep 18, 2026 |
| Jacqueline B Kosecoff | Director | Mar 17, 2026 |
| Margaret M Mccarthy | Director | Mar 17, 2026 |
| Mark B. Mcclellan | Director | Mar 17, 2026 |
| Nicholas Robbert Vorhoff | Director | Mar 17, 2026 |
Executive officers
| Name | Title | Latest filing |
|---|---|---|
| Sebastian Burzacchi | COO - Mgmt Services Org | Mar 19, 2026 |
| James M Head | Chief Financial Officer | Apr 8, 2026 |
| Shane J. Hochradel | Chief Operations Officer | Jul 2, 2026 |
| Christopher J Joyce | Chief Legal and Admin. Officer | Apr 1, 2026 |
| John E Kao | Chief Executive Officer | Sep 16, 2026 |
| Joseph S Konowiecki | EVP, Corporate Affairs | Sep 18, 2026 |
| Mark D. Kent | President - MSO | Jun 9, 2026 |
| Hyong Kim | Chief Medical Officer | Jun 15, 2026 |
| Adnan R. Mansour | Chief Digital Officer | Mar 17, 2026 |
| Dawn Christine Maroney | President | Sep 11, 2026 |
| Robert L. Scavo | Chief Information Officer | Mar 19, 2026 |
| Andreas P. Wagner | Chief Human Resources Officer | Mar 19, 2026 |
Recent insider buys & sales
| Date | Insider | Type | Shares | Price |
|---|---|---|---|---|
| Sep 17, 2026 | Joseph S Konowiecki | Sale | 23,511 | $8.61 |
| Sep 17, 2026 | Joseph S Konowiecki | Sale | 23,511 | $8.61 |
| Sep 17, 2026 | Joseph S Konowiecki | Sale | 23,511 | $8.61 |
| Sep 17, 2026 | Joseph S Konowiecki | Sale | 23,511 | $8.61 |
| Sep 14, 2026 | John E Kao | Sale | 27,400 | $13.00 |
| Sep 14, 2026 | John E Kao | Sale | 27,400 | $13.00 |
| Sep 14, 2026 | John E Kao | Sale | 27,400 | $13.00 |
| Sep 14, 2026 | John E Kao | Sale | 27,400 | $13.00 |
| Sep 11, 2026 | John E Kao | Sale | 385,270 | $12.68 |
| Sep 11, 2026 | John E Kao | Sale | 385,270 | $12.68 |
| Sep 11, 2026 | John E Kao | Sale | 385,270 | $12.68 |
| Sep 11, 2026 | John E Kao | Sale | 385,270 | $12.68 |
| Sep 11, 2026 | Dawn Christine Maroney | Sale | 122,707 | $12.68 |
| Sep 11, 2026 | Dawn Christine Maroney | Sale | 122,707 | $12.68 |
| Sep 11, 2026 | Dawn Christine Maroney | Sale | 122,707 | $12.68 |
ALHC financials (annual, from XBRL filings)
| Fiscal year end | Revenue | Net income | Diluted EPS | Operating cash flow |
|---|---|---|---|---|
| Dec 31, 2025 | — | $-724.00K | 0.00 | $139.93M |
| Dec 31, 2024 | — | $-128.03M | -0.67 | $34.77M |
| Dec 31, 2023 | $1.80B | $-148.02M | -0.79 | $-59.19M |
| Dec 31, 2022 | $1.43B | $-149.55M | -0.83 | $-45.43M |
| Dec 31, 2021 | $1.17B | $-195.29M | -1.14 | $-78.78M |
Latest balance sheet: total assets $1.28B, total liabilities $1.01B, cash $693.45M (as of Jun 30, 2026).
ALHC earnings / results-day log
| Date | Filing | Close that day |
|---|---|---|
| Jul 30, 2026 | 8-K Item 2.02 (results) | $18.61 |
| Apr 30, 2026 | 8-K Item 2.02 (results) | $22.54 |
| Feb 26, 2026 | 8-K Item 2.02 (results) | $20.42 |
| Oct 30, 2025 | 8-K Item 2.02 (results) | $17.12 |
| Jul 30, 2025 | 8-K Item 2.02 (results) | $13.00 |
| May 1, 2025 | 8-K Item 2.02 (results) | $16.77 |
| Feb 27, 2025 | 8-K Item 2.02 (results) | $13.47 |
| Oct 29, 2024 | 8-K Item 2.02 (results) | $11.71 |
| Aug 1, 2024 | 8-K Item 2.02 (results) | — |
| May 2, 2024 | 8-K Item 2.02 (results) | — |
| Feb 27, 2024 | 8-K Item 2.02 (results) | — |
| Nov 2, 2023 | 8-K Item 2.02 (results) | — |
Related stocks · Hospital & Medical Service Plans
UnitedHealth (UNH)Humana (HUM)Elevance Health (ELV)Cigna (CI)Centene (CNC)Oscar Health (OSCR)Molina Healthcare (MOH)Clover Health Investments (CLOV)Trupanion (TRUP)
Popular today
Spdr S&P 500 Etf (SPY)Micron Technology (MU)Nvidia (NVDA)Meta Platforms (META)Sandisk (SNDK)AMD (AMD)Space Exploration Technologies (SPCX)Tesla (TSLA)Apple (AAPL)Intel (INTC)Microsoft (MSFT)Amazon (AMZN)
More on ALHC
Information only, not investment advice. BuyMeWhiskey is not a registered investment adviser or broker-dealer; nothing here is a recommendation to buy, sell or hold any security, and there are no price targets. Data comes from SEC EDGAR filings and public end-of-day market data and may be delayed or contain errors. Verify with the company's filings before making decisions. Prices: end-of-day data as of Oct 16, 2026, 4:00 PM ET. Filings: SEC EDGAR. Updated after every US trading day.